Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain SPPI message board posts where the ticker symbol SPPI has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest SPPI SEC Filings

Filings Format Description Filing Date File/Film Number
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-18-054844 Size: 5 KB
2018-10-11
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-18-046055 Size: 5 KB
2018-08-09
10-Q  Documents   Interactive Data Quarterly report [Sections 13 or 15(d)]
Acc-no: 0000831547-18-000063 (34 Act)  Size: 12 MB
2018-08-09 001-35006
181005314
8-K  Documents Current report, items 2.02 and 9.01
Acc-no: 0000831547-18-000061 (34 Act)  Size: 327 KB
2018-08-09 001-35006
181005012
SC 13G/A  Documents [Amend] Statement of acquisition of beneficial ownership by individuals
Acc-no: 0000932471-18-006531 (34 Act)  Size: 34 KB
2018-08-08 005-49329
181002197
SC 13D/A  Documents [Amend] General statement of acquisition of beneficial ownership
Acc-no: 0001171520-18-000354 (34 Act)  Size: 7 MB
2018-07-31 005-49329
18978873
11-K  Documents Annual report of employee stock purchase, savings and similar plans
Acc-no: 0000831547-18-000057 (34 Act)  Size: 272 KB
2018-06-26 001-35006
18919580
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-18-039492 Size: 5 KB
2018-06-26
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-18-038687 Size: 7 KB
2018-06-19
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-18-038684 Size: 7 KB
2018-06-19
More SPPI SEC Filings


Related news from
Fri, 19 Oct 2018
12:28:26 +0000
The Daily Biotech Pulse: Novartis Positive Liver Drug Trials, Krytstal Prices Offering, LogicBio To Debut
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech stocks hitting 52-week highs on Oct. 18) Endocyte, Inc. (NASDAQ: ECYT )( announced a deal to ...
Thu, 18 Oct 2018
11:00:00 +0000
Spectrum Pharmaceuticals Announces Dr. Francois Lebel as Chief Medical Officer
Spectrum Pharmaceuticals, Inc. (SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced the appointment of Francois Lebel, M.D., F.R.C.P.C. as Chief Medical Officer, effective November 5, 2018. “Dr. Lebel is an accomplished leader and has deep expertise in biopharmaceuticals with an emphasis in oncology drug development,” said Joe Turgeon, President and CEO of Spectrum Pharmaceuticals. “Given his qualifications, we believe Dr. Lebel will add significant value to Spectrum and our clinical programs.
Fri, 12 Oct 2018
14:14:02 +0000
Options Traders Expect Huge Moves in Spectrum Pharmaceuticals (SPPI) Stock
Spectrum Pharmaceuticals (SPPI) needs investors to pay close attention to the stock based on moves in the options market lately.
Wed, 03 Oct 2018
22:45:00 +0000
Top 4 Small-Cap Stocks for 2018
Looking at growth outlooks and price targets, these four small-cap stocks could be stellar for the rest of 2018.
Thu, 27 Sep 2018
11:00:00 +0000
Spectrum Pharmaceuticals to Present Corporate Update at the 2018 Cantor Global Healthcare Conference on October 2
Spectrum Pharmaceuticals (SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that an overview of the company's business strategy and commercial and development-stage programs will be given at the 2018 Cantor Global Healthcare Conference being held in New York. A live webcast of Spectrum's presentation will be available at http://www.sppirx.com. Spectrum Pharmaceuticals is a leading biotechnology company focused on acquiring, developing, and commercializing drug products, with a primary focus in hematology and oncology.
Tue, 25 Sep 2018
14:46:54 +0000
Why All Analysts Covering Spectrum Pharmaceuticals Are Bullish
Spectrum Pharmaceuticals (SPPI) is a biotechnology company focused on advancing its late-stage investigational drugs, such as poziotinib, eflapegrastim, and apaziquone, to address unmet need across multiple oncology indications. Spectrum Pharmaceuticals has reported a YTD (year-to-date) return of 12.72% in 2018. Analysts have projected a 12-month consensus target price of $34.5 for Spectrum, which is 61.52% higher than its closing price on September 21.
Mon, 24 Sep 2018
15:40:00 +0000
Spectrum Pharmaceuticals Announces Release of Updated Poziotinib Data From MD Anderson Phase 2 Study in Non-Small Cell Lung Cancer Patients
Spectrum Pharmaceuticals, Inc. (SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced preliminary poziotinib data from the University of Texas, MD Anderson Cancer Center Phase 2 non-small cell lung cancer (NSCLC) study which were released today during an oral presentation at the IASLC 19th World Conference on Lung Cancer hosted by the International Association for the Study of Lung Cancer. The MD Anderson study is the single largest data set of patients with an exon 20 mutation in EGFR or HER2.
Thu, 13 Sep 2018
17:35:04 +0000
Is Spectrum Pharmaceuticals Inc (NASDAQ:SPPI) A Financially Strong Company?
Small-caps and large-caps are wildly popular among investors; however, mid-cap stocks, such as Spectrum Pharmaceuticals Inc (NASDAQ:SPPI) with a market-capitalization of US$2.22b, rarely draw their attention. While they are lessRead More...
Thu, 13 Sep 2018
13:13:01 +0000
Spectrum Pharma Includes First-Line NSCLC in Poziotinib Study
Spectrum Pharma (SPPI) amends poziotinib study protocol to include two cohorts to evaluate it in first-line lung cancer.
Wed, 12 Sep 2018
11:00:00 +0000
Spectrum Pharmaceuticals Expands Poziotinib Clinical Trial Into First-Line Therapy and Doses First Patient
Spectrum Pharmaceuticals, Inc. (SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that it has initiated two new cohorts for first-line, locally advanced or metastatic non-small cell lung cancer (NSCLC) patients with EGFR or HER2 exon 20 insertion mutations in its current Phase 2 non-small cell lung cancer (NSCLC) clinical trial. Spectrum also announced that it has dosed the first patient in the expanded patient population.
Fri, 07 Sep 2018
18:25:02 +0000
A Look at Spectrum’s Financial Position in September
In the second quarter, Spectrum Pharmaceuticals (SPPI) generated net revenues of $24.2 million compared to $34.3 million in Q2 2017. In the first half of the year, Spectrum Pharmaceuticals reported net revenues of $54.7 million compared to $63.4 million in H1 2017.
Fri, 07 Sep 2018
16:50:53 +0000
Why Spectrum Pharmaceuticals Stock Rose ~5% on September 6
On September 6, Spectrum Pharmaceuticals stock closed at $22.25, which is a ~5.70% rise from its close of $21.05 on September 5, 2018. On September 6, Spectrum Pharmaceuticals stock price closed at $22.25, which represents ~146% growth from its 52-week low of $9.03 on September 22, 2017. Spectrum Pharmaceuticals hit its 52-week high of $25.29 on August 27, 2018.
Fri, 07 Sep 2018
12:57:12 +0000
Spectrum Pharmaceuticals (SPPI) Catches Eye: Stock Jumps 5.7%
Spectrum Pharmaceuticals (SPPI) shares rose nearly 6% in the last trading session, amid huge volumes.
Thu, 06 Sep 2018
12:28:49 +0000
The Daily Biotech Pulse: Novartis Divestment, Eyepoint's Drug Gets Coverage, Spectrum's Robust Data
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on Sept. 5) Aptinyx Inc (NASDAQ: APTX ) Avanos Medical Inc (NYSE: AVNS ...
Thu, 06 Sep 2018
12:00:00 +0000
Today's Research Reports on Trending Tickers: Spectrum Pharmaceuticals and NovoCure
NEW YORK, NY / ACCESSWIRE / September 6, 2018 / Major U.S. equities were mixed on Wednesday with tech stocks posting worst daily drop since July dragging Nasdaq lower. The Dow Jones Industrial Average ...
Wed, 05 Sep 2018
21:21:00 +0000
Spectrum Pharmaceuticals Announces Release of Poziotinib Abstract as Part of the IASLC 19th World Conference on Lung Cancer
HENDERSON, Nev.-- -- The abstract reported new interim data from the EGFR cohort and, for the first time, the HER2 cohort in the MD Anderson Phase 2 trial In the EGFR cohort, an objective response rate of 58% and a disease control rate of 90% were reported In the HER2 cohort, an objective response rate of 50% and a disease control rate of 83% were reported Updated data will be presented in an oral ...
Sun, 02 Sep 2018
13:41:19 +0000
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings
The biotech sector notched strong gains last week, capitalizing on the positive overall market sentiment, set in motion by the trade deal between the U.S. and Mexico. Here are a few catalysts that could ...
Fri, 31 Aug 2018
12:44:12 +0000
Implied Volatility Surging for Spectrum Pharmaceuticals (SPPI) Stock Options
Investors in Spectrum Pharmaceuticals (SPPI) need to pay close attention to the stock based on moves in the options market lately.
Fri, 31 Aug 2018
12:15:00 +0000
Report: Exploring Fundamental Drivers Behind International Bancshares, Morgan Stanley, Equity Residential, Hormel Foods, Spectrum Pharmaceuticals, and Cousins Properties — New Horizons, Emerging Trends, and Upcoming Developments
NEW YORK, Aug. 31, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of International ...



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "I absolutely LOVE ValueForum, and consider this site the most important tool I have for investing and/or trading because of the incredible information at just one site. I have learned so much from reading messages posted here that I recommend to the new comer to select an area of investing that is of interest and then read those posts starting with most current. I am sure you will gain information and learn techniques that can be applied to other areas/sectors of investing. This is an 'Invaluable' forum." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards